Endothelial implants inhibit intimal hyperplasia after porcine angioplasty

Circulation Research

Volumn 84, Issue 4, 1999, Pages 384-391

  Nugent, Helen M ^a,c   Rogers, Campbell ^a,b   Edelman, Elazer R ^a,b  

^a HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Heparin; Perivascular; Restenosis; Thrombosis; Tissue engineering

Indexed keywords

ANGIOPLASTY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; CAROTID ARTERY; CATTLE; CELL TRANSPLANTATION; CONTROLLED STUDY; ENDOTHELIUM CELL; IMMUNOCYTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; RESTENOSIS;

EID: 0033525545     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.84.4.384     Document Type: Article

References (56)

1. Rubanyi GM. The role of endothelium in cardiovascular homeostasis and diseases. J Cardiovasc Pharmacol 1993;22:S1-S14.
2. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;288: 373-376.
3. Autio I, Maol-Ranta RU, Kallioniemi OP, Nikkari T. Cultured bovine aortic endothelial cells secrete factor(s) chemotactic for aortic smooth muscle cells. Artery. 1989;16:72-83.
4. Cybulsky MI, Gimbrone MA. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 1991;251: 788-791.
5. Casscells W. Migration of smooth muscle and endothelial cells. Critical events in restenosis. Circulation. 1992;86:723-729.
6. Castellot JJ, Addonizio ML, Rosenberg RD, Karnovsky MJ. Cultured endothelial cells produce a heparin-like inhibition of smooth muscle growth. J Cell Biol. 1981;90:372-379.
7. Nugent MA, Karnovsky MJ, Edelman ER. Vascular cell-derived heparan sulfate shows coupled inhibition of basic fibroblast growth factor binding and mitogenesis in vascular smooth muscle cells. Circ Res. 1993;73:1051-1060.
8. Fischell TA, Derby G, Tse TM, Stadius ML. Coronary artery vasoconstriction routinely occurs after percutaneous transluminal coronary angioplasty. Circulation. 1988;78:1323-1334.
9. El-Tamimi H, Davies GJ, Hackett D, Sritara P, Bertrand O, Crea F, Maseri A. Abnormal vasomotor changes early after coronary angioplasty. A quantitative arteriographic study of their time course. Circulation. 1991;84:1198-1202.
10. Castaneda-Zuniga WR, Formanek A, Tadavarthy M, Vlodaver Z, Edwards JE, Zollikofer C, Amplatz K. The mechanism of balloon angioplasty. Radiology. 1980;135:565-571.
11. Edelman ER, Nugent MA, Smith LT, Karnovsky MJ. Basic fibroblast growth factor enhances the coupling of intimal hyperplasia and proliferation of vasa vasorum in injured rat arteries. J Clin Invest. 1992;89: 465-473.
12. Langer R, Vacanti JP. Tissue engineering. Science. 1993;260:920-925.
13. Nabel EG, Plautz G, Boyce FM, Stanley JC, Nabel GJ. Recombinant gene expression in vivo within endothelial cells of the arterial wall. Science. 1989;244:1342-1344.
14. Messina LM, Podrazik RM, Whitehill TA, Ekhterae D, Brothers TE, Wilson JM, Burkel WE, Stanley JC. Adhesion and incorporation of lacZ-transduced endothelial cells into the intact capillary wall in the rat. Proc Natl Acad Sci USA. 1992;89:12018-12022.
15. Conte MS, Birinyi LK, Miyata T, Fallon JT, Gold HK, Whitemore AD, Mulligan RC. Efficient repopulation of denuded rabbit arteries with autologous genetically modified endothelial cells. Circulation. 1994;23: 2161-2169.
16. Wilson JW, Birinyi LK, Salomon RN, Libby P, Callow AD. Mulligan RC. Implantation of vascular grafts lined with genetically modified endothelial cells. Science. 1989;244:1344-1346.
17. Dichek DA, Neville RF, Zwiebel JA, Freeman SM, Leon MB, Anderson WF. Seeding of intravascular stents with genetically engineered endothelial cells. Circulation. 1989;80:1347-1353.
18. Nathan A, Nugent MA, Edelman ER. Tissue engineered perivascular endothelial cell implants regulate vascular injury. Proc Natl Acad Sci USA. 1995;92:8130-8134.
19. Huber KC, Schwartz RS, Edwards WD, Camrud AR, Bailey KR, Jorgenson MA, Holmes DJ. Effects of angiotensin converting enzyme inhibition on neointimal proliferation in a porcine coronary injury model. Am Heart J. 1993;125:695-701.
20. Lam JY, Lacoste L, Bourassa MG. Cilazapril and early atherosclerotic changes after balloon injury of porcine carotid arteries. Circulation. 1992;85:1542-1547.
21. Churchill DA, Siegel CO, Moinor ST, West MS, Raizner AE. Enalapril in the prevention of restenosis following intracoronary intervention in a swine model. Coron Artery Dis. 1993;4:461-467.
22. Huckle WR, Drag MD, Acker WR, Powers M, McFall RC, Holder DJ, Fujita T, Stabilito II, Kim D, Ondeyka DL, Mantlo NB, Chang RSL, Reilly CF, Schwartz RS, Greenlee WJ, Johnson RG. Effects of subtype-selective and balanced angiotensin II receptor antagonists in a porcine coronary artery model of vascular restenosis. Circulation. 1996;93: 1009-1019.
23. Kornowski R, Hong MK, Tio FO, Choi SK, Bramwell O, Leon MB. A randomized animal study evaluating the efficacies of locally delivered heparin and urokinase for reducing in-stent restenosis. Coron Artery Dis. 1997;8:293-298.
24. 1 receptor antagonists. Effects on smooth muscle cell migration and proliferation after balloon catheter injury. Am J Pathol. 1991;139:1291-1296.
25. 1, and basic fibroblast growth factor depends on release kinetics and extracellular matrix interactions. J Biol Chem. 1996;271: 29822-29829.
26. Nathan A, Katada M, Edelman ER. Perivascular heparin delivery using biodegradable polymers. Polym Mater Sci Eng. 1994;70:320-321.
27. Edelman ER, Adams DA, Karnovsky MJ. Effect of controlled adventitial heparin delivery on smooth muscle cell proliferation following endothelial injury. Proc Natl Acad Sci USA. 1990;87:3773-3777.
28. Edelman ER, Karnovsky MJ. Contrasting effects of the intermittent and continuous administration of heparin in experimental restenosis. Circulation. 1994;89:770-776.
29. Bonan R, Paiement P, Scortichini D, Cloutier M-J, Leung TK. Coronary restenosis: evaluation of a restenosis injury index in a swine model. Am Heart J. 1993;126:1334-1340.
30. Schneider JE, Berk BC, Gravanis MB, Santoian EC, Cipolla GD, Tarazona N, Lassegue B, King SB. Probucol decreases neointimal formation in a swine model of coronary artery balloon injury. Circulation. 1993;88:628-637.
31. Tanimoto T, Ohtsuki Y. Evaluation of antibodies reactive with porcine lymphocytes and lymphoma cells in formalin-fixed, paraffin-embedded, antigen-retrieved tissue sections. Am J Vet Res. 1996;57:853-859.
32. Bjornsson TD, Dryjski M, Tluczek J, Mennie R, Ronan J, Mellin TN, Thomas KA. Acidic fibroblast growth factor promotes vascular repair. Proc Natl Acad Sci USA. 1991;88:8651-8655.
33. Ferns G, Reidy M, Ross R. Vascular effects of cyclosporine A in vivo and in vitro. Am J Pathol. 1990;137:403-413.
34. Liu MW, Roubin GS, Robinson KA, Black AJ, Hearn JA, Siegel RJ, King SB. Trapidil in preventing restenosis after balloon angioplasty in the atherosclerotic rabbit. Circulation. 1990;81:1089-1093.
35. Lehmann KG, Doria RJ, Feuer JM, Hall PX, Hoang DT. Paradoxical increase in restenosis rate with chronic heparin use: final results of a randomized trial. J Am Coll Cardiol. 1991;17:181A. Abstract.
36. Ellis SG, Roubin GS, Wilentz J, Douglas JSJ, King SBI. Effect of 18 to 24 hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty. Am Heart J. 1989;117:777-782.
37. Leach CM, Thorburn GD. A comparative study of collagen-induced thromboxane release from platelets of different species: implications for human atherosclerosis models. Prostaglandins. 1982;24:47-59.
38. Steele PM, Chesebro JH, Stanson AW, Holmes JR, Dewanjee MK, Badimon L, Fuster V. Balloon angioplasty. Natural history of the pathophysiological response to injury in a pig model. Circ Res. 1985;57: 105-112.
39. Karas SP, Gravanis MB, Santoian C, Robinson K, Anderberg KA, King SB. Coronary intimal proliferation after balloon injury and stenting in swine: an animal model of restenosis. J Am Coll Cardiol. 1992;20: 467-474.
40. Herring M, Gardner A, Glover J. A single staged technique for seeding vascular grafts with autologous endothelium. Surgery. 1978;84:498-504.
41. Absolom DR, Hawthorn LA, Chang G. Endothelialization of polymer surfaces. J Biomed Mater Res. 1988;22:271-285.
42. van Wachem PB, Beugeling T, Feijen J, Bantjes A, Detmers JP, van Aken WG. Interaction of cultured human endothelial cells with polymeric surfaces of different wettabilities. Biomaterials. 1985;6:403-408.
43. Hubbell JA, Massia SP, Desai NP, Drumheller PD. Endothelial cell-selective materials for tissue engineering in the vascular graft via a new receptor. Biotechniques. 1991;9:568-572.
44. Clowes AW, Karnovsky MJ. Suppression by heparin of smooth muscle cell proliferation in injured arteries. Nature. 1977;265:625-626.
45. Clowes AW, Clowes MM, Reidy MA. Kinetics of cellular proliferation after arterial injury. III: endothelial and smooth muscle growth in chronically denuded vessels. Lab Invest. 1986;54:295-303.
46. Clowes AW, Clowes MM, Fingerle J, Reidy MA. Kinetics of cellular proliferation after arterial injury. V: role of acute distension in the induction of smooth muscle proliferation. Lab Invest. 1989;60:360-364.
47. Clowes AW, Clowes MM. Kinetics of cellular proliferation after arterial injury, II: inhibition of smooth muscle growth by heparin. Lab Invest. 1985;52:611-616.
48. Buchwald AB, Unterberg C, Nebendahl K, Grone HJ, Wiegand V. Low-molecular-weight heparin reduces neointimal proliferation after coronary stent implantation in hypercholesterolemic minipigs. Circulation. 1992; 86:531-537.
49. De Scheerder I, Wang K, Wilczek K, Meuleman D, Van Amsterdam R, Vogel G, Piessens J, Van de Werf F. Experimental study of thrombogenicity and foreign body reaction induced by heparin-coated coronary stents. Circulation. 1997;95:1549-1553.
50. Nabel EG. Biology of the impaired endothelium. Am J Cardiol. 1991;68: 6C-8C.
51. Furchgott RF, Vanhoutte PM. Endothelium-derived relaxing and contracting factors. FASEB J. 1989;3:2007-2018.
52. Gertler JP, Abbott WM. Prothrombic and fibrinolytic function of normal and perturbed endothelium. J Surg Res. 1992;52:89-95.
53. Bobik A, Campbell JH. Vascular derived growth factors: cell biology, pathophysiology, and pharmacology. Pharmacol Rev. 1993;45:1-42.
54. Robinson D, Halperin N, Nevo Z. Fate of allogeneic embryonal chick chondrocytes implanted orthotopically, as determined by the host's age. Mech Ageing Dev. 1989;50:71-80.
55. Wakitani S, Kimura T, Hirooka A, Ochi T, Yoneda M, Yasui N, Owaki H, Ono K. Repair of rabbit articular surfaces with allograft chondrocytes embedded in collagen gel. J Bone Joint Surg (Br). 1989;71:74-80.
56. Stone KR, Walgenbach AW, Abrams JT, Nelson J, Gillett N, Galili U. Porcine and bovine cartilage transplants in cynomolgus monkey, I: a model for chronic xenograft rejection. Transplantation. 1997;63: 640-645.